Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abandoned, adjudication, affiliated, affirmative, Alan, Alexander, Allegiance, amortizable, Angle, Approx, arbitration, Article, ASD, augment, Avista, aware, backflow, ball, barrel, Baxter, BBA, bidding, Biological, Biomedical, Bourne, Bournebecame, Burgstahler, Campbell, Canada, CAPA, Carbothane, Cardinal, cast, cessation, Charter, Chase, Chico, Cirrex, cited, Clairborne, closure, CMI, College, complainant, compromising, conclusion, constant, contamination, covenant, CVP, David, default, defective, designee, devivo, disadvantage, disapproval, discarded, disconnection, discrimination, dismissed, dismissing, Distributorship, drawn, dual, EEOC, element, Embarc, endosurgery, escrow, estimatable, Eurodollar, expenditure, extinguishment, Extrusion, Fargo, Fenner, fifteen, Flexcil, FLOWSCONSOLIDATED, Fluoromax, footprint, foundation, frame, Ft, Geck, George, Germany, GP, GPO, green, Greiner, Hamburg, Hologic, Hybrid, IDE, IDN, Implantaable, imposition, intention, investigation, Investigational, iridium, John, joinder, JPMorgan, Justice, Kapusta, Kapustajoined, leaving, leverage, leveraged, LifePort, likelihood, Lowell, Lynch, manifold, manipulation, Matthew, MBA, MDR, Meditech, Merrill, Michigan, Microbiology, microcatheter, microwave, midst, mL, month, Morgan, Morse, Myeloma, Nashua, Nephew, Nit, NM, occlusion, Ontario, OPS, Optiguide, OurXcela, PaineWebber, pancreatic, Panzer, parenteral, partnership, PASV, patency, payoff, percent, Perceptor, Pharmacia, Pharmacy, physical, Pierre, plaintiff, polymer, polysulfone, polyurethane, preceding, preserve, promptly, proportion, protocol, psi, purporting, radiolucence, radiopacity, randomized, rationalizing, reallocated, reassigned, recapitalization, reclassification, reject, relocation, repaid, repurchase, resigned, revolver, revolving, Richard, Richmond, Rivier, RO, Robertson, robust, seal, septum, shutdown, signature, silicone, smallest, Sohi, solicitation, solicited, spearheaded, Spotlight, Sq, Squeeze, Sriram, Stark, Station, sterile, Stewart, study, superselective, temporarily, tenure, thereof, thin, threshold, timeframe, torque, transducer, Trauma, Truimph, TYCO, unaudited, unexpected, unused, Upjohn, Utah, Valleylab, valve, valved, VascPak, Vaxcel, VenaCureEVLT, Venkataraman, viability, VII, VP, VpMTA, vu, vulnerable, Woodside, Xcela, XII, zone
Removed:
advertisement, Advertising, aforementioned, aggregating, amortizing, ANGIOFLOW, annum, architectural, arrange, arterial, assembled, Biosphere, block, cancelled, collateralization, collectibility, compressible, contingently, convenient, driven, embolic, entering, favor, feeding, floor, geographical, Hydrogel, IDA, inception, Indenture, infringed, injected, invoicing, land, largest, LIBOR, location, lot, malformation, matured, maturing, Medtronic, occupancy, owner, parental, people, recast, recruitment, referred, reinstatement, remarketing, rent, reprice, repriced, reserve, resold, rollover, Saturday, secondary, shop, shrink, spending, spouse, subordinated, supplied, Thirty, traceability, transparency, trust, VASC
Filing tables
Filing exhibits
- 10-K Annual report
- 21 Subsidiaries
- 23 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification by the Chief Executive Officer Pursuant to Section 302
- 31.2 Certification by the Chief Financial Officer Pursuant to Section 302
- 32.1 Certification by the Chief Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification by the Chief Financial Officer Pursuant to 18 U.s.c. Section 1350
Related press release
ANGO similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-120057, No. 333-138456, No. 333-140627, No. 333-161355, No. 333-162844, No. 333-170619) of AngioDynamics, Inc. of our report dated August 14, 2012 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Albany, New York
August 14, 2012